What are the side effects of sodium valproate sustained-release tablets?
After taking sodium valproate sustained-release tablets, there may be side effects such as liver function impairment and neurological disorders. If this medication is required, regular liver function tests should be performed during the course of administration. It is also important to take the medication under the guidance of a doctor and avoid self-medication, as it may lead to a series of side effects.
1. Sodium valproate sustained-release tablets can be used to treat some generalized seizures, partial epilepsy, and special types of syndromes. The adult dosage is 200-400mg each time, taken 2-3 times daily. It is recommended to start with a small dose and follow the doctor's instructions.
2. Sodium valproate sustained-release tablets are used to treat generalized and partial epileptic seizures as well as special types of syndromes. The adult dosage is 200-400mg each time, taken 2-3 times daily. It is recommended to start with a small dose and follow the doctor's instructions.
3. Although rare, there is a risk of teratogenicity due to liver function impairment and neurological disorders after taking sodium valproate sustained-release tablets (see pregnancy). However, patients should not be overly concerned. Proper medication usage can reduce the occurrence of side effects.
4. During the treatment with Depakine (sodium valproate sustained-release tablets), a small number of patients may experience lethargy or stupor, leading to transient coma (encephalopathy). This may occur alone or concurrently with epileptic seizures during the treatment process.
